Syncona Portfolio LTD Autolus Therapeutics PLC Transaction History
Syncona Portfolio LTD
- $38.6 Million
- Q2 2025
A detailed history of Syncona Portfolio LTD transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Syncona Portfolio LTD holds 16,640,720 shares of AUTL stock, worth $26.3 Million. This represents 98.24% of its overall portfolio holdings.
Number of Shares
16,640,720
Previous 16,640,720
-0.0%
Holding current value
$26.3 Million
Previous $25.8 Million
47.09%
% of portfolio
98.24%
Previous 97.79%
Shares
4 transactions
Others Institutions Holding AUTL
# of Institutions
100Shares Held
165MCall Options Held
0Put Options Held
39.3K-
Wellington Management Group LLP Boston, MA27.1MShares$42.9 Million0.01% of portfolio
-
Blackstone Inc New York, NY20.5MShares$32.4 Million0.22% of portfolio
-
Mak Capital One LLC New York, NY17MShares$26.8 Million5.54% of portfolio
-
Deep Track Capital, LP Greenwich, CT16.9MShares$26.6 Million1.36% of portfolio
-
Armistice Capital, LLC New York, NY12MShares$19 Million0.48% of portfolio
About Autolus Therapeutics plc
- Ticker AUTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 90,909,800
- Market Cap $144M
- Description
- Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...